The ATM protein kinase regulates the DNA damage response by phosphorylating proteins involved in cell cycle checkpoints and DNA repair. We report here on the function of the predicted leucine zipper (LZ) motif, and sequences adjacent to this, in regulating ATM activity. The predicted LZ sequence was deleted from ATM, generating ATMDLZ, and expressed in an ATM-negative AT cell line. ATM increased cell survival following exposure to ionizing radiation, whereas expression of ATMDLZ failed to increase cell survival. ATMDLZ retained in vitro kinase activity, but was unable to phosphorylate p53 in vivo. Leucine zippers mediate homoand heterodimerization of proteins. However, the predicted LZ of ATM did not mediate the formation of ATM dimers. We examined if the predicted LZ of ATM was a dominant-negative inhibitor of ATM function in SW480 cells. Expression of amino acids 769-1436 of ATM, including the predicted LZ, sensitized SW480 cells to ionizing radiation, but did not inhibit ATM's kinase activity or its ability to phosphorylate Brca1. Further, this dominant-negative activity was not dependent on the predicted LZ domain. The central region of the ATM protein therefore contains multiple sequences which regulate cell survival following DNA damage.
Introduction
The ATM protein is mutated in the inherited disease ataxia telangiectasia (AT). AT is characterized by immunodeficiency, cerebellar ataxia, increased incidence of cancer, and extreme sensitivity to ionizing radiation (IR; Luo et al., 1996; Meyn, 1999) . Cells from AT patients exhibit radioresistant DNA synthesis, genetic instability (Taylor et al., 1975; Cornforth and Bedford, 1985; Meyn, 1999) , spontaneous DNA recombination, poor fidelity during repair (Meyn, 1993; Luo et al., 1996) , and do not undergo potentially lethal damage repair. Further, AT cells are defective in the activation of cell cycle checkpoints at G1, during S phase and in G2 (Kastan et al., 1992; Beamish et al., 1996) .
The ATM protein is a 3056 amino-acid protein containing a C-terminal kinase domain (Savitsky et al., 1995) . ATM phosphorylates multiple proteins involved in the DNA damage response, including p95/nibrin (Lim et al., 2000; Zhao et al., 2000) , Brca1 (Cortez et al., 1999) , the p53 tumor-suppressor gene (Banin et al., 1998; Canman et al., 1998) , the checkpoint kinase chk2 (Blasina et al., 1999; Matsuoka et al., 2000) , SMC1 (Banin et al., 1998; Kim et al., 2002; Yazdi et al., 2002) , BLM (Beamish et al., 2002) , FANCD2 (Taniguchi et al., 2002) , and Pin2/Trf1 (Kishi et al., 2001) . The phosphorylation of these proteins by ATM can regulate their functional activity. Further, genetic inactivation of ATM's kinase activity inhibits all of ATM's function , indicating that the kinase activity of ATM is an essential component of the signal transduction pathway by which ATM activates the DNA damage response. However, the mechanism of ATM activation by DNA damage is not known.
The ATM protein contains several predicted functional domains. These include the C-terminal kinase domain (amino acids 2865-2900), as well as a region which is broadly conserved between the FRAP, ATM, and TRRAP proteins (amino acids 2138-3056; Bosotti et al., 2000) . The N-terminal region of ATM contains an essential region which may be required for association of ATM with its substrates ). In addition, there is a predicted leucine zipper (LZ) repeat located between amino acids 1216 and 1241 which is conserved between human and murine ATM (Savitsky et al., 1995) . LZs are a-helical structures containing leucine at every seventh position (Groves and Barford, 1999) . The leucine side chains of the LZ extend outwards from the helix and mediate interaction with the LZs of adjacent proteins (Groves and Barford, 1999) . This has led to speculation that the predicted LZ may facilitate the interaction between ATM and specific regulatory proteins (Morgan et al., 1997) . In support of this, experiments have shown that the region of ATM containing the predicted LZ sensitizes normal cells to IR (Morgan et al., 1997) , suggesting that this region of ATM exerts a dominant-negative effect on endogenous ATM protein. However, whether this dominant-negative effect is due to the predicted LZ or some other region has not been determined. Further, the LZ in ATM has an atypical structure, containing a proline between the third and fourth leucines of the repeat. Prolines disrupt the helical structure of proteins (Groves and Barford, 1999) , indicating that the LZ of ATM may not assume a classical LZ helical structure.
Here, we examined if the predicted LZ of ATM is required for the activation of ATM. The predicted LZ, covering amino acids 1217-1239 of ATM (LVLEWLNLQDTEYNLSSFPFILL), was deleted from the full-length ATM (FLAT) protein. ATMDLZ retained in vitro kinase activity, but was unable to restore normal radiosensitivity to AT cells or phosphorylate p53 in vivo. Further, the LZ did not appear to act as a functional site for the formation of ATM dimers either in vivo or in vitro. A fragment of ATM containing the LZ (amino acids 769-1436) could sensitize SW480 cells to IR. Deletion of the LZ from this fragment did not significantly alter the ability of amino acids 769-1436 to sensitize SW480 cells to IR. Thus, although the LZ of ATM is an essential functional domain of the ATM protein, it does not posses dominant-negative inhibitory activity towards the endogenous ATM protein.
Results
We have determined the functional role of the region of ATM containing the predicted LZ motif. Previous work demonstrated that expression of a small fragment of ATM (amino acids 811-1241) containing the predicted LZ sensitizes cells to IR (Morgan et al., 1997) . It has been suggested that the predicted LZ mediates this dominant-negative effect on cellular radiosensitivity through interaction of ATM's predicted LZ with key regulatory proteins. However, a direct analysis of this hypothesis has not yet been undertaken. To determine the role of the predicted LZ of ATM, we deleted amino acids 1217-1239, containing the predicted LZ, from the full-length ATM protein. This construct, termed ATMDLZ, was then stably expressed in the AT cell line GM5849, which lacks endogenous ATM expression. In Figure 1a , pooled clonal populations of AT cells transfected with full-length ATM or ATMDLZ were examined for ATM expression by Western blotting. ATM was not detected in vector-transfected AT cells (Figure 1a, p3) , whereas both FLAT and ATMDLZ were efficiently expressed at equivalent levels. Additional controls for ATM antibody specificity and ATM expression are in Figure 1b or as previously published by us . We have observed that multiple passage of the ATMDLZ cells leads to a decrease in expression of ATMDLZ. In Figure 1a , ATMDLZ can be readily detected three passages postselection (Figure 1a, p3 ), but expression is undetectable after eight passages (Figure 1a, p8) . In contrast, FLAT levels were unchanged during passage in culture. This suggests that ATMDLZ protein may be unstable, or exhibits toxicity in the AT cells. The exact reason for the loss in ATMDLZ protein expression is under investigation. Accordingly, experiments on ATMDLZ were only carried out on cells within four passages of transfection, and expression levels were routinely checked by Western blot analysis.
To determine how deletion of the predicted LZ inactivates ATM, we determined if deleting the predicted LZ affected ATM's kinase activity. In Figure 1b , GM637 cells, which express endogenous ATM, were examined for ATM immunokinase activity. No ATM kinase activity was detected with nonspecific antibody, or in the absence of substrate (Figure 1b ). In the presence of both ATM antibody and substrate, ATM immunokinase activity was detected. Vector-transfected AT cells did not exhibit ATM kinase activity, whereas cells expressing FLAT or ATMDLZ displayed similar levels of kinase activity (Figure 1b, GM5849) . Deletion of the predicted LZ from ATM does not therefore affect ATM's in vitro kinase activity.
In Figure 2 , the ability of ATMDLZ to restore a normal DNA damage response to GM5849 AT cells was examined. Cells were exposed to either IR or the radiomimetic agent bleomycin to induce strand breaks. Expression of FLAT in AT cells led to an increase in cell survival when the cells were exposed to IR (Figure 2a) . However, expression of ATMDLZ in AT cells did not alter the extreme radiosensitivity of AT cells (Figure 2a ). When cells were exposed to the radiomimetic agent bleomycin, expression of full-length ATM led to increased cell survival, whereas expression of ATMDLZ did not alter the increased sensitivity of AT cells to bleomycin. This result was not due to loss of ATMDLZ The results from Figures 1 and 2 indicate that amino acids 1217-1239, containing the predicted LZ, are essential for ATM to regulate radiosensitivity, but are not required for kinase activity. Two possible explanations for this were considered. First, ATM's kinase activity and its ability to regulate cell survival may be separate functions of the ATM protein. Second, although ATMDLZ retains in vitro kinase activity, it may be unable to phosphorylate ATM target proteins in vivo. We therefore determined if ATMDLZ could phosphorylate serine 15 of the p53 protein in vivo (Banin et al., 1998) . Both GM637 and GM5849 cells are transformed by the SV40 virus and express SV40Tag. SV40 Tag protein binds to and stabilizes p53, resulting in elevated levels of p53 (Hess and Brandner, 1997; Kohli and Jorgensen, 1999; . Changes in p53 protein levels after DNA damage are therefore not usually detected in SV40-transformed cells (Kohli and Jorgensen, 1999) . Consequently, as expected, p53 protein levels in GM637, GM5849 or GM5849 cells expressing ATM were not altered by exposure to IR (Figure 3a ; lower panel). In some experiments, there was a small increase in p53 protein levels when AT cells expressing ATMDLZ were irradiated, but this was not consistently seen in all experiments. Next, we determined if ATM and ATMDLZ could phosphorylate serine 15 of p53 in vivo using a phospho-specific antibody. GM637 cells showed increased phosphorylation of serine 15 of p53 following exposure to IR ( Figure 3a , upper panel), whereas AT cells transfected with vector did not phosphorylate serine 15 of p53. AT cells expressing FLAT displayed a small increase in serine 15 phosphorylation following exposure to IR, whereas cells expressing ATMDLZ were unable to phosphorylate serine 15 of p53. This implies that although ATMDLZ has in vitro kinase activity, it is unable to phosphorylate p53 in vivo. However, expression of FLAT in AT cells did not restore p53 (m) were either irradiated at the indicated doses or exposed to bleomycin for 2 h. After 10-14 days, surviving colonies were stained with crystal violet and cell survival measured using standard clonogenic cell survival assays. Results7s.e.m. FLAT was significantly different from vector and ATMDLZ cells (t-test, Po0.05; n ¼ 12)
Figure 3 ATMDLZ does not phosphorylate p53. (a) Stable expression. GM637 cells, or AT5849 cells stably expressing vector, ATM or ATMDLZ were irradiated (4 Gy) and allowed to recover for 15 or 60 min. Proteins were separated by SDS-PAGE and p53 identified using either an antiphosphoserine-15 antibody (upper panel: Ser-p15) or p53 antibody Ab421 (lower panel: p53). (b) Transient expression. Upper panel: GM5849 cells were transiently transfected with vector, p53 or p53 with a serine-to-alanine mutation at position 15 (p53.S15A). p53 was detected with antip53 antibody Ab421. Lower panel: GM5849 cells were transiently transfected with vector (Con), p53, p53.S15A, ATM or ATMDLZ as indicated. At 24 h after transfection, cells were irradiated (4 Gy: þ ) and p53 phosphorylation detected using antiphosphoserine-15 antibody 1 h later phosphorylation to the same level as that seen in GM637 cells (Figure 3a) . This is not due to low-level expression, since AT cells expressing FLAT and GM637 cells have similar levels of ATM kinase activity (Figure 1b) . We have noted that p53 from the GM5849 cells consistently had a small but significantly faster etectrophoretic mobility on SDS-PAGE than p53 from GM637 cells (Figure 3a ). This can be seen clearly in Figure 3b , where transient transfection of wild-type p53 into GM5849 cells results in the detection of a slower mobility wild-type p53 (Figure 3b , Exo) and the faster migrating endogenous p53 protein (Figure 3b , Endo). It is unclear whether this difference results from differential post-translational modification, the presence of the SV40 Tag protein or a mutation/deletion within the p53 from GM5849 cells. Since this difference might interfere with the observed results, and affect the ability of ATM to efficiently phosphorylate p53, we sought to confirm our result in a different experimental system. GM5849 cells were transiently transfected with wildtype p53 in the absence or presence of various ATM constructs. We have used this approach previously to demonstrate that ATM can directly regulate p53 transcriptional activity . Further, to test the specificity of the phospho-p53 antibody, we also used a wild-type p53 expression vector with a serine to alanine mutation at serine 15. In Figure 3b , GM5849 cells were transiently transfected with vector, p53 or p53S15A. The transfected p53 has a slower electrophoretic mobility than the endogenous p53 from GM5849 cells (Figure 3b , upper panel) and can be readily distinguished by Western analysis. GM5849 cells were then transfected with p53, p53S15A, ATM or ATMDLZ as indicated, irradiated, and phosphorylation of serine 15 detected with the phospho-p53 antibody. Western blots were carried out to ensure equal expression levels of the ATM and p53 proteins (BD Price, unpublished observation). In Figure 3b , the lower, intense band present in each lane represents the endogenous p53 phosphorylated on serine 15. This phosphorylation was constant under all conditions, and is due to p53 phosphorylation resulting form the transfection protocol, as we have previously shown . Cells transfected with vector, p53 or p53S15A (Figure 3b : Con, p53, p53S15A) alone did not reveal any significant phosphorylation of the transfected p53. However, when p53 and ATM were cotransfected, significant phosphorylation of the transfected p53 was seen, and this was increased following exposure of the cells to IR (Figure 3b: p53 ATM) . In contrast, cotransfection of p53S15A with ATM did not reveal any basal or stimulated phosphorylation of p53 by ATM. This result confirms that the phospho-p53 antibody is detecting phosphorylation of serine 15 of p53 and that this occurs in an ATM-dependent manner. Significantly, cotransfection of ATMDLZ with p53 did not lead to detectable phosphorylation of serine 15 of p53 either in the absence or presence of IR.
These results clearly demonstrate that the region of ATM containing the predicted LZ is essential to the correct functioning of the ATM protein. Deletion of the predicted LZ region prevents ATM from correcting the increased sensitivity of AT cells to IR. Further, ATMDLZ retains in vitro kinase activity, but is unable to phosphorylate p53 in vivo. One explanation is that the predicted LZ region of ATM provides an essential interaction surface required for ATM to phosphorylate its substrates in vivo. For example, the predicted LZ may be required for the formation of active ATM dimers, or for interaction of ATM with DNA repair complexes. To distinguish between these possibilities, we first examined if the predicted LZ of ATM mediates ATM homodimerization. A region from the center of the ATM protein (amino acids 769-1436), containing the predicted LZ (amino acids 1217-1239), was tagged with either FLAG or Omni epitopes. These fragments, referred to as pCD1-Omni and pCD1-Flag, were in vitro translated, mixed, and then immunoprecipitated with antibodies specific for each fragment to determine if they were capable of self-association. The results are shown in Figure 4 . Input radiolabeled proteins are shown to the right of Figure 4 . The size difference between the pCD1-Omni and pCD1-Flag proteins reflects the different sizes of the FLAG and Omni epitopes. When reactions were immunoprecipitated with IgG, no radiolabeled protein was detected (Figure 4 , IgG). When the reactions were immunoprecipitated with Flag antibody, pCD1-Flag was always detected, but no co-precipitating pCD1-Omni was seen (Figure 4 , FLAG). When reactions were immunoprecipitated with Omni antibody, pCD1-Omni was always detected, but no co-precipitating pCD1-Flag was detected (Figure 4 , Omni). These results demonstrate that the pCD1 fragment, containing amino acids 769-1436 of ATM, does not self-associate in this in vitro translation system. In addition, we have expressed both pCD1-FLAG and pCD1-Omni in human cell lines, and subjected them to immunoprecipitation with FLAG and Omni antibodies. These data also failed to reveal any direct interaction between the fragments in vivo (BD Price, unpublished observation). These results indicate that the pCD1 fragment of ATM does not mediate self-association under the conditions we have examined. It is possible that such interactions only occur within the context of the full length ATM protein, or that such interactions are transient or too weak to be detected by this technique. 
ATM's leucine domain is essential S Chen et al
The predicted LZ region is essential for ATM to regulate radiosensitivity (Figure 2 ). Figure 4 indicates that pCD1 does not form homodimers, implying that ATM's predicted LZ is not a dimerization motif. ATM's predicted LZ may therefore mediate the interaction between ATM and a key regulatory protein. In the next series of experiments, we examined if the predicted LZ domain of ATM exerts a dominant-negative inhibitory effect on endogenous ATM function. pCD1, containing amino acids 769-1436, or pCD1DLZ, from which the predicted LZ domain (amino acids 1217-1239) was deleted, were inserted into the pcDNA3.1/HisA expression vector. SW480 cells, a human colon adenocarcinoma cell line, were transfected with these constructs and pooled, clonal stable cell lines were established. In Figure 5 , transfected cells were immunoprecipitated with either IgG or Omni antibody, and protein expression confirmed by Western blot. pCD1 or pCD1DLZ, encoding proteins of predicted mass 73.4 and 70.8 kDa, respectively, were both efficiently expressed in SW480 cells. A nonspecific band was also detected by the Omni antibody in SW480 cells ( Figure 5 ). We next determined how expression of these fragments affected the radiosensitivity of SW480 cells pCD1 efficiently sensitized SW480 cells to IR (Figure 5b: ') . However, SW480 cells expressing pCD1DLZ were also sensitized to IR (Figure 5b : &). Although pCD1DLZ appeared less efficient at sensitizing SW480 cells to IR, the difference between pCD1 and pCD1DLZ was not considered statistically significant (Figure 5: legend) . Thus, amino acids 769-1436 of ATM contain a critical functional domain which sensitizes SW480 cells to IR. However, this effect is independent of the predicted LZ sequence (amino acids 1217-1239). Amino acids 769-1436 of ATM may therefore contain additional uncharacterized sequences.
To further examine the mechanism by which pCD1 sensitizes SW480 cells to IR, we determined if ATM's kinase activity was altered by pCD1 expression. SW480 cells immunoprecipitated with nonspecific anti-sera ( Figure 6: upper panel, À) or AT cells immunoprecipitated with ATM antibody had no detectable kinase activity (Figure 1 ). SW480 cells transformed with vector or pCD1DLZ had equivalent levels of ATM kinase activity, whereas SW480 cells expressing pCD1 had slightly higher levels of ATM kinase activity. To determine if the in vivo kinase activity of ATM was affected by pCD1 expression, we examined the phosphorylation of Brca1 by ATM (Cortez et al., 1999; Li et al., 2000) . Previous work has shown that ATM phosphorylates Brca1 following exposure to IR, causing a well-defined decrease in the mobility of the Brca1 protein on SDS-PAGE (Gatei et al., 2000a) . In Figure 6 (lower panel), normal GM637 fibroblast cells and GM5849 AT fibroblast cells were irradiated and Brca1 examined by Western blotting. GM637 cells showed an increase in Brca1 mobility after irradiation, which was not seen in AT cells. SW480 cells transfected with vector substrate. Phosphorylated proteins were separated by SDS-PAGE and detected by autoradiography. Brca1 phosphorylation (lower panel): Cells were irradiated (10 Gy) and allowed to recover for 1 or 2 h. Cell extracts were separated by SDS-PAGE and Brca1 detected by Western blotting. GM637: normal fibroblasts; GM5849: AT fibroblasts; SW: SW480 adenocarcinoma cells stably transfected with either Vector (SW.vec), pCD1 (SW.CD1) or pCD1DLZ (SW. DLZ) ATM's leucine domain is essential S Chen et al alone displayed marked increases in Brca1 mobility following exposure to IR, and this was not significantly altered by expression of either pCD1 or pCD1DLZ. This demonstrates that although expression of pCD1 and pCDDLZ can sensitize SW480 cells to IR, this effect is not associated with significant changes in either ATM kinase activity or the ATM-dependent phosphorylation of the Brca1 protein.
Discussion
We have shown that deletion of the predicted LZ domain blocks the ability of ATM to complement the increased radiosensitivity of AT cells. Although ATMDLZ retained normal in vitro kinase activity, it was unable to phosphorylate and activate the p53 protein in vivo. Thus, the predicted LZ of ATM is required for ATM to regulate cell survival and p53 activation. Further, the central domain of ATM (amino acids 769-1436), when expressed as a dominant-negative fragment in SW480 cells, sensitized these cells to IR. This dominant-negative activity was not dependent on the predicted LZ. This central domain of ATM did not block either the in vitro kinase activity of endogenous ATM or the ATM-dependent phosphorylation of Brca1 in vivo. Thus, the central region of ATM contains multiple protein motifs which regulate cell survival following exposure to IR. Several explanations for the inability of ATMDLZ to complement the increased radiosensitivity of AT cells can be considered. ATM's protein structure is sensitive to mutations or deletions, which frequently inactivate ATM's kinase activity (Chenevix-Trench et al., 2002; Scott et al., 2002) . ATMDLZ retained in vitro kinase activity, indicating that deletion of the predicted LZ does not have a major impact on the structure of the ATM protein. Truncating mutations in ATM produce protein products which are unstable and are rapidly degraded (Izatt et al., 1999; Meyn, 1999) . FLAT and ATMDLZ were expressed at similar levels during early passage in culture. However, expression of ATMDLZ was lost during passage in culture, whereas FLAT was stable for multiple generations. ATMDLZ may be unstable or toxic to the cell, resulting in the selection of cells expressing little or no protein. The reason for the apparent toxicity of ATMDLZ is currently under investigation.
As ATMDLZ had normal in vitro kinase activity, we determined if ATMDLZ could phosphorylate the p53 protein in vivo. Using two distinct assays, we were unable to detect any phosphorylation of p53 by ATMDLZ in vivo. The predicted LZ domain of ATM is therefore required for the ATM-dependent phosphorylation of the p53 protein in vivo. ATM also phosphorylates Nbs1, Brca1, BLM, and other ATM target proteins (Kim et al., 1999; Gatei et al., 2000a, b; Kastan et al., 2001; Kishi et al., 2001; Beamish et al., 2002) . The phosphorylation of these proteins by ATM is required for cells to survive IRinduced DNA damage. Since ATMDLZ does not phosphorylate p53 in vivo, it may be unable to phosphorylate other ATM substrates in vivo. The failure of ATMDLZ to complement the increased radiosensitivity of AT cells is likely due to the inability of ATMDLZ to phosphorylate essential target proteins in vivo. The results also show that the in vitro kinase activity of ATM can be dissociated from its ability to phosphorylate the p53 protein in vivo.
We next examined how the predicted LZ domain may regulate ATM function. LZs mediate protein-protein interactions, including the formation of homo-or heterodimeric proteins. ATM is part of a large multiprotein complex (Wang et al., 2000) and may be a functional dinner . The predicted LZ may regulate interactions between ATM and target proteins in vivo, or direct the formation of active ATM dimers. However, we did not observe any dimerization of protein fragments of ATM in either in vivo or in vitro protein-protein interaction systems. We interpret this to mean that ATM's predicted LZ is not involved in the dimerization of ATM under the conditions tested.
Amino acids 811-1261 of ATM can sensitize human tumor cells line to IR (Morgan et al., 1997) , and this effect was suggested to be caused by the predicted LZ region. We tested this proposition by expressing pCD1 (amino acids 769-1436 of ATM) in SW480 cells to determine if it had dominant-negative activity on ATM function. This was based on the premise that pCD1 would compete with the endogenous ATM for interaction with regulatory proteins and therefore impair ATM activation. pCD1 increased the radiosensitivity of SW480 cells 2.5-fold at 4 Gy ( Figure 5 ). However, AT cells are usually 5-10-fold more sensitive to IR than normal cells (Taylor et al., 1975) , implying that pCD1 only partially inhibits endogenous ATM function in SW480 cells. Partial inhibition of ATM by pCD1 would result in levels of radiosensitivity intermediate between normal and AT cells, as seen. When the predicted LZ was deleted from pCD1, SW480 cells expressing pCD1DLZ had similar radiosensitivity to SW480 cells expressing pCD1 ( Figure 5 ). The dominant-negative activity associated with pCD1 is therefore not mediated by the predicted LZ of ATM. This implies that pCD1 contains additional sequences outside the predicted LZ domain which exert dominant-negative effects on cellular radiosensitivity. Indeed, pCD1 did not block the ability of ATM to phosphorylate Brca1 in response to IR, whereas deletion of the predicted LZ from FLAT blocked in vivo phosphorylation of p53. These opposing effects on in vivo phosphorylation events indicate that the LZ domain and pCD1 may be involved in separate functions of the ATM protein.
The predicted LZ in ATM is conserved between several mammalian species (Savitsky et al., 1995; Pecker et al., 1996) , and in the ATM-related protein DNAPKcs (Yavuzer et al., 1998) . The predicted LZ in ATM has an atypical structure, containing a proline between the third and fourth leucines of the repeat. Prolines disrupt the helical structure of proteins (Groves and Barford, 1999) , suggesting that the predicted LZ of ATM may not assume a classical LZ helical structure. Further, the predicted LZ domain is contained within a leucine-rich region, with seven of the 23 residues being leucine. It therefore remains possible that it is not a functional LZ. Additional studies, including mutagenesis and identification of proteins that interact with the predicted LZ of ATM will be required to determine if this sequence is a functional LZ.
The predicted LZ of ATM is essential for the correct functioning of the ATM protein. However, it is not a site for ATM dimerization. The predicted LZ domain may be required for interaction with regulatory proteins or DNA repair complexes, or may target ATM to the correct cellular location. Further, the ability of the pCD1 fragment to sensitize SW480 cells to IR indicates that sequences adjacent to the predicted LZ are also essential. The presence of these potential sites for protein-protein interaction suggests that the central region of the ATM protein may provide a platform for the interaction of ATM with DNA repair complexes. Further characterization of this domain will provide key insights into the signal transduction pathway which links IR-induced DNA damage leads to the activation of the ATM protein.
Experimental proceedures
Cells and transfection GM637 (normal) or GM5849 (AT) human fibroblast cell lines (Coriel Institute, Camden, NJ, USA) were cultured in Minimal Eagle's Media with 10% fetal bovine serum. SW480 cells (American Type Culture Collection, VA, USA) were cultured in Ham's F-12 medium with 10% fetal bovine serum. Transfection of cells using Lipofectin (Life Technologies, CA, USA) and measurement of clonogenic cell survival with Crystal Violet were as previously described by us (Price and Youmell, 1996; . Stable cell lines were selected in G418 (400 mg/ml) for 7-10 days, and pooled clonal populations prepared. For transient transfection, 0.8 Â 10 6 GM5849 cells were transfected with p53 vectors (80 ng) or ATM vectors (700 ng) or equivalent amounts of vector. At 24 h after transfection, cells were irradiated and then lysed as described below. p53 and p53.S15A expression vectors are as previously described by us .
Western blot and kinase assays
Cells (1 Â 10 7 ) were lysed in ATM lysis buffer (20 mm HEPES pH 7.4, 150 mm NaCl, 0.2% Tween 20, 1.5 mm MgCl 2 , 1 mm EGTA, 2 mm DTT, 50 mm NaF, 500 mm NaVO 4 , 1 mm PMSF, aprotinin 0.1 mg/ml, leupeptin 0.1 mg/ml) and cleared by centrifugation. Lysates were incubated with Omni-antibody (Santa Cruz, CA, USA) or ATM antibody PC116 (Oncogene Science, NY, USA) for 2 h, and immunoprecipitated for 1 h with 30 ml of Protein A-sepharose (50% w/v; Pharmacia, NJ, USA).
Samples were washed three times in ATM lysis buffer, and once each in high-salt buffer (100 mm Tris, pH 7.4/ 600 mm NaCl/1 mm DTT/1 mm PMSF), and base buffer (10 mm HEPES, pH 7.4/10 mm MgCl 2 /50 mm NaCl/ 1 mm DTT/1 mm PMSF). For Western blotting, ATM was solubilized in Laemmli's sample buffer and proteins separated by 6% denaturing polyacrylamide electrophoresis. Proteins were transferred to nylon membranes and ATM detected with either Omni or PC116 antibodies as previously described by us . For immunokinase assay, immunoprecipitates were washed once in kinase buffer (10 mm HEPES pH 7.4/10 mm MgCl 2 /50 mm NaCl/10 mm MnCl 2 ), then incubated in 35 ml kinase buffer supplemented with 50 mm ATP, 0.5 mg GST-Chk2 1-89 , and 10 mCi g-32 P ATP for 30 min at 301C. The reaction was terminated with 4 Â Laemmli's sample buffer, proteins separated by 12% SDS-PAGE and visualized by autoradiography. For p53 Westerns, cells were lysed in ATM lysis buffer and protein (12 mg) separated by SDS-PAGE. After transfer to nylon, membranes were developed consecutively with p53 antibody Ab421 followed by phosphop53.S15A antibody (1 : 10 000 dilution; Ab3, Oncogene Science, CA, USA).
Plasmid construction
The LZ of ATM, located between amino acids 1217 and 1239, was deleted by PCR. Plasmid pCD1, encoding amino acids 769-1436 of ATM as a BamH1/Xho1 fragment in pcDNA3.1/HisA, was the target for PCR. Two primers, LZ1 (AACTACACAAATGAGGAT-TTC) and LZ2 (ATAATCTAAATGAGATGCCATA-AAGTC), were annealed to opposite strands of plasmid pCD1 with their 5 0 -ends located at position 3648 (amino acid 1216) and position 3718 (amino acids 1240) of the ATM cDNA. The ExSite PCR site-directed mutagenesis kit (Stratagene, CA, USA), was used to PCR amplify the plasmid. Cycling conditions were: 1 min at 941C; 2 min at 601C; 8 min at 721C for eight cycles using pfuTurbo. Linear plasmid, termed pCD1DLZ, lacking amino acids 1217-1239 of ATM, was religated, and clones containing the required deletion identified by DNA sequencing. To construct FLAT, pCD1DLZ was digested with BamH1/Xho1, releasing amino acids 774-1365, and ligated into BamHI/Xho1-digested pNT, which contains amino acids 1-773 in the vector pcDNA3.1/HisA, to yield pNTDLZ. pNTDLZ, containing amino acids 1-1365, was digested with kpn1, releasing amino acids 1-1303. This fragment was then ligated into kpn1-digested pFLAT, resulting in FLAT, minus the LZ at amino acids 1217-1239, expressed in pcDNA3.1/HisA.
In vitro translation
Plasmids were in vitro translated using the TNT T7/T3 Coupled Reticulocyte Lysate System (Promega Corp, WI, USA). pCD1 was inserted into both pcDNA3.1/ HisA and pCMV-Tag1 to give pCD1-Omni and pCD1-Flag, respectively. Each vector was in vitro translated in the presence of 35 S-methionine, and equal aliquots of each incubated in IT buffer for 1 h at 41C. Reactions were then incubated for 1 h with either anti-Flag, antiOmni antibody or IgG, followed by 1 h with Protein ASepharose. Immunoprecipitates were washed in 3 Â 1 ml of IT buffer (20 mm Tris pH 7.4/50 mm NaCl/1 mm MgCl 2 /0.1% Triton X-100/1 mm PMSF/1 mm DTT), proteins separated by SDS-PAGE, and visualized by autoradiography.
